Effect of pirfenidone in patients with more advanced idiopathic pulmonary fibrosis

Data from controlled clinical studies in patients with more advanced idiopathic pulmonary fibrosis (IPF) could inform clinical practice, but they are limited, since this sub-population is usually excluded from clinical trials. These exploratory post-hoc analyses of the open-label, long-term extensio...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Respir Res
Asıl Yazarlar: Costabel, Ulrich, Albera, Carlo, Glassberg, Marilyn K., Lancaster, Lisa H., Wuyts, Wim A., Petzinger, Ute, Gilberg, Frank, Kirchgaessler, Klaus-Uwe, Noble, Paul W.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2019
Konular:
Letter to the Editor
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6416878/
https://ncbi.nlm.nih.gov/pubmed/30866942
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-019-1021-2
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller